Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.
Manuel Sánchez CánovasMiguel Ángel Moya HernándezEvdochia AdoamneiDiego Cacho LavinDavid Fernández GarayTeresa Quintanar VerdúguezJacobo Rogado RevueltaFrancisco José García VerdejoSilvia García AdriánAna Isabel Ferrer PérezMaría Esperanza Guirao GarcíaJavier López RoblesJaime MendiolaAndrés J Muñoz MartínPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Thromboembolic disease associated with immunotherapy in patients with head and neck neoplasia does not significantly impact survival. The presence of liver metastases can predict these events.